TPToan Duong Pham

Toan Duong Pham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toan Duong Pham has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Efficacy of a Manual Microfluidic Dish Compared with the Discontinuous Gradient Centrifugation Method for Sperm Selection in ICSI Cycles

    by Thanh N.D. Pham, My T.T. Nguyen, Vu N.A. Ho, Duy L. Nguyen, Toan D. Pham, Nhu T.M. Khong, Duong N.A. Tran, Phuong T.M. Nguyen, Cam T. Tran, Anh T.K. Phan, et al.

    Introduction: Microfluidic sperm selection systems (MFSSs) have emerged as centrifugation-free alternatives to conventional sperm preparation methods, such as density gradient centrifugation (DGC), which may induce oxidative stress and sperm DNA damage. Although commercial MFSS devices have shown potential benefits, their clinical use is limited by cost and reliance on proprietary systems. Manual MFSS has been proposed as a simplified and cost-effective alternative. However, the clinical effectiveness of MFSS, particularly in relation to embryological and clinical outcomes in intracytoplasmic sperm injection (ICSI), remains largely unvalidated. Aims: To evaluate whether manual MFSS improves sperm quality and clinical outcomes compared with DGC in ICSI cycles. Methods: This prospective cohort study was conducted at My Duc Hospital, HCMC, Vietnam and included couples undergoing ICSI between February and November 2024. The primary outcome was the Day-3 embryo formation rate. Secondary outcomes included sperm motility, morphology, fertilisation, blastocyst development and clinical pregnancy outcomes. Between-group comparisons were performed using the t-test, Mann–Whitney U test or Fisher’s exact test, as appropriate. A p-value [Formula: see text] was considered statistically significant. Results: Sixty couples were included, with 30 undergoing sperm preparation using MFSS or 30 using DGC. The Day-3 embryo formation rate did not differ significantly between the MFSS and DGC groups (83% vs 94%, [Formula: see text]). Compared with DGC, MFSS resulted in significantly higher progressive motility (91.8% vs 82.4%, [Formula: see text]) and significantly lower proportions of immotile sperm (0.3% vs 8.5%, [Formula: see text]) and sperm with head abnormalities (80.8% vs 88.5%, [Formula: see text]); sperm concentration was higher in the DGC group. Fertilisation, blastocyst development and clinical pregnancy outcomes were comparable between the two groups (all [Formula: see text]). Conclusions: Use of MFSS achieved similar embryological and clinical outcomes to use of DGC while improving sperm motility and morphology.

  • Open Access

    Effect of super-growth differentiation factor-9 (GDF9) during capacitation in vitro maturation of oocytes from small antral follicles: an exploratory pilot study

    by Lan N Vuong, Kha T Huynh, Toan D Pham, Cam T Tran, Vu NA Ho, Minh Hn Nguyen, Xuyen Th Le, Ho L Le, Nhu Tm Khong, Anh H Le, et al.

    This pilot study determined the effect of adding Super-growth differentiation factor-9 (GDF9) to capacitation in-vitro maturation (CAPA-IVM) culture media on oocyte maturation and blastocyst formation. The study was conducted at an academic infertility center in Vietnam in January–February 2025. Cumulus-oocyte complexes (COCs) were obtained from consenting subfertile women aged 18–35 years who had polycystic ovary syndrome, ≥30 COCs at oocyte pick-up (OPU) in a CAPA-IVM cycle, and were willing to donate ≥10 COCs for research purposes. COCs from sibling human oocytes were treated without (control) or with Super-GDF9 (50 ng/mL) added to CAPA-IVM capacitation and maturation cultures. All metaphase II (MII) oocytes were inseminated using intracytoplasmic sperm injection. The primary endpoint was proportion of blastocysts at end of culture (per patient/per COCs). For per-patient outcomes, only the median [interquartile range] rate of good-quality blastocysts per total blastocysts differed significantly between the Super-GDF9 (0.0 [0.0, 0.0]) and control (83.3 [16.7, 100.0]) groups (effect size [95% confidence interval] –50.0 [–100.0, 0.0]; p=0.02). There were no good-quality blastocysts in the Super-GDF9 group. The rate of blastocysts (per COCs and per day-3 embryos) tended to be lower in the Super-GDF9 group. Adding Super-GDF9 to the current CAPA-IVM protocol did not improve blastocyst formation and showed a trend toward lower blastocyst formation, which requires confirmation in adequately powered studies.


  • Open Access

    Frozen Versus Fresh Embryo Transfer in IVF – An Individual Participant Data Meta-Analysis of Randomised Controlled Trials (INFORM)

    by Rui Wang, Nicole Au, Daimin Wei, David Nguyen, Ze Wang, Yun Sun, KeLiang Wu, Richard S. Legro, Lan N. Vuong, Toan D. Pham, et al.

    Background: Results from randomised trials comparing a freeze-all versus a fresh embryo transfer strategy in in-vitro fertilisation have shown conflicting results, and it is unclear which individuals would benefit most from each transfer policy. We aimed to compare freeze-all and fresh embryo transfer strategies in patients undergoing in vitro fertilization (IVF) and to identify those who benefit most from either strategy.Methods: We conducted an individual participant data (IPD) meta-analysis. We searched MEDLINE, Embase, PsycINFO, CENTRAL, The Cochrane Gynaecology and Fertility Group Specialised Register and clinical trial registries to identify randomised trials comparing a freeze-all and a fresh embryo transfer strategy in individuals undergoing IVF up until 24 September 2025. We performed a two-stage IPD meta-analysis adjusting for important prognostic factors (female age and body mass index (BMI)). The primary outcome was live birth following the first embryo transfer and the safety outcomes were moderate to severe ovarian hyperstimulation syndrome (OHSS) and major congenital anomaly. We investigated treatment-covariate interactions on prespecified baseline covariates. We evaluated the risk of bias using ROB 2 tool. This study was registered with PROSPERO (CRD42021296566).Findings: Among 16 eligible trials, IPD from 13 trials involving 9060 randomised participants (96% of eligible participants) were obtained. IPD meta-analysis showed no evidence that a freeze-all embryo transfer strategy differed from a fresh embryo transfer on live birth rate following the first transfer (adjusted risk ratio (aRR) 1.00, 95% confidence interval (CI) 0.86 to 1.17, moderate-certainty evidence). Compared to a fresh embryo transfer strategy, a freeze-all embryo transfer strategy resulted in lower rates of moderate or severe OHSS (11 studies, 8144 participants, aRR 0.28, 95% CI 0.18 to 0.43, high-certainty evidence) and major congenital anomaly (8 studies, 6905 participants, aRR 0.73, 95% CI 0.63 to 0.85, moderate-certainty evidence). Subgroup analyses showed a non-linear interaction between serum progesterone levels on trigger day and the treatment effects of a freeze-all versus a fresh transfer strategy, with patients with higher progesterone levels (especially over 1.5 ng/ml) more likely to benefit from a freeze-all strategy. No strong evidence of subgroup effects was observed for other baseline covariates.Interpretation: In unselected IVF population, the freeze-all and fresh embryo transfer strategies are comparable in terms of live birth rate following the first transfer, and freeze-all reduced the rates of OHSS and major congenital anomaly. Patients with significant risk of OHSS or with elevated progesterone levels on the day ovulation is triggered benefit more from a freeze-all strategy. The findings support a personalised approach for clinical decision making.

  • Open Access

    Efficacy of Different Endometrial Preparation Protocols for Frozen Embryo Transfer in Patients with Caesarean Section Scar Defect

    by Van T.T. Tran, Vu N.A. Ho, Tri C. Nguyen, Toan D. Pham, Phuong N.H. Le, Rui Wang, Wentao Li, Ben W. Mol, Tuong M. Ho, Lan N. Vuong

    Background: Recent studies have suggested a potential correlation between having a caesarean section scar defect (CSD) and reduced success rates in frozen embryo transfer (FET) cycles after in vitro fertilisation (IVF). However, comprehensive data on this association remain limited. Aim: To investigate the influence of different endometrial preparation protocols in women with CSD undergoing FET. Methods: This retrospective cohort study enrolled women between March 2020 and February 2023 at two hospitals in Vietnam. Participants were aged 18–42 years, had regular menstruation, had [ ] previous IVF cycles, and underwent FET with artificial cycle (AC) or natural cycle (NC)/modified NC endometrial preparation. The primary outcome was the live birth rate after the first FET following CSD diagnosis. Results: We studied 130 patients (98 in the AC group and 32 in the NC group). The live birth rate did not differ significantly between the AC and NC groups (22.4% vs. 21.9%; RR 1.03, 95% confidence interval [CI] 0.48–2.17; [ ]), but the positive [ ]-human chorionic gonadotropin (hCG) rate was significantly higher in the AC group (46.9% vs. 25%, relative risk (RR) 1.88, 95% confidence interval [CI] 1.09–4.25; [ ]). The miscarriage rate at [ ] weeks was substantially higher in the AC group (14.3%) than in the NC group (3.12%) (RR 4.57, 95% CI 0.63–33.41; [ ]). Conclusion: Endometrial preparation method may not affect the live birth rate in women with CSD undergoing FET. Differences in positive pregnancy tests and clinical pregnancies might indicate a benefit for the AC group. However, as miscarriage occurred less with NC, clinicians should consider the miscarriage rate when choosing the AC protocol in this setting.

  • Open Access

    Impact of glucose metabolism abnormalities on live birth rate in South-East Asian women with polycystic ovary syndrome

    by Nam T Nguyen, Vu N A Ho, Toan D Pham, Minh H N Nguyen, Duy L Nguyen, Ho L Le, Khanh T Q Le, Luong D Ly, Mai T N Tran, Tuong M Ho, et al.

    Is there a difference in live birth rates at 24 months between infertile women with polycystic ovary syndrome (PCOS) who have normal versus abnormal glucose metabolism? Abnormal glucose metabolism did not significantly reduce live birth rates but was associated with increased obstetric complications. Women with PCOS are often at increased risk of glucose metabolism disorders. However, evidence about the impact of these disorders on pregnancy outcomes remains limited, particularly in Asian populations. This prospective cohort study was conducted at a reproductive care centre in Vietnam from June 2020 to August 2024. A total of 1208 women were enrolled. Eligible participants were infertile women aged 18–40 years diagnosed with PCOS (Rotterdam criteria). Comprehensive assessments included medical history, anthropometric measurements, endocrine evaluations, fasting plasma glucose (FPG), glycosylated haemoglobin (HbAlc), and oral glucose tolerance tests (OGTT). Participants were categorized into normal or abnormal glucose metabolism groups and monitored for live birth outcomes at 24 months from the first visit. Live birth rates at 24 months were comparable between women with normal versus abnormal glucose metabolism (52.7% vs 48.2%, P = 0.12). However, obstetric complications, including gestational diabetes mellitus (15.2% vs 28.0%, P < 0.001) and hypertensive disorders of pregnancy (2.3% vs 9.0%, P < 0.001), were more common in the group with abnormal glucose metabolism. In women who conceived naturally, greater waist circumference and higher Homeostatic Model Assessment of Insulin Resistance index were significantly associated with lower odds of live birth, whereas the presence of hyperandrogenism was associated with higher odds of live birth. No factors were significantly associated with live birth in the group that conceived via ovulation induction plus IUI. In the group that conceived through IVF or IVM, a higher BMI was significantly associated with a lower live birth rate. This single-centre study was conducted exclusively on infertile women from South-East Asia who had PCOS, potentially limiting generalizability to other populations. Additionally, metabolic assessments were only performed at baseline, preventing evaluation of longitudinal changes and their dynamic effects on reproductive outcomes. While no significant difference in live birth rates was observed between PCOS women with normal and abnormal glucose metabolism, the abnormal glucose metabolism group experienced higher rates of gestational complications. These findings underscore the importance of preconception metabolic screening and tailored fertility strategies that include targeted interventions to optimize reproductive and maternal outcomes in women with PCOS. This study was supported by My Duc Hospital. Lan N. Vuong reports funding from the Vietnam National Foundation for Science and Technology Development (NAFOSTED; grant number FWO.108-2022.01); Merck: Speaker and conference fees; Merck Sharp and Dohme: speaker and conference fees as well as a grant; Ferring: speaker, conference, and scientific board fees outside the submitted work. All other authors declare no conflicts of interest. NCT04364087.


  • Open Access

    Psychomotor Development of Children Born from Couples Undergoing Intracytoplasmic Sperm Injection with Assisted Oocyte Activation

    by Nam T. Nguyen, Minh H. N. Nguyen, Nghia A. Nguyen, Van T. T. Tran, Ha T. Nguyen, Thu T. M. Vo, Tri C. Nguyen, Anh T. K. Phan, Tram L. Ho, Bao G. Huynh, et al.

    Background: Assisted oocyte activation (AOA) has been used to improve fertilization rates after intracytoplasmic sperm injection (ICSI) by artificially increasing oocyte calcium concentration. However, concerns remain about its potential long-term impact on child development. Limited data exist on developmental outcomes in children born after ICSI with AOA. This study investigated psychomotor development at 12 months of age in children born after ICSI with or without AOA. Methods: This prospective cohort study included 55 children born after frozen embryo transfer: 29 in the AOA group and 26 in the non-AOA group. At 12 months, parents completed the Ages and Stages Questionnaire, Third Edition (ASQ-3), and the Developmental Milestones Red Flags checklist, validated for assessing psychomotor development. Parents also reported their child’s physical characteristics (e.g., height and weight) and medical history, including hospital admissions and chronic illnesses. Outcomes included proportions of children with abnormal ASQ-3 scores, Red Flag signs, and adverse medical/growth outcomes. Results: Baseline parental and perinatal characteristics were comparable between groups. At 12 months, no significant differences were observed in the proportion of children with abnormal ASQ-3 scores across five developmental domains (communication, gross motor, fine motor, personal-social, and problem-solving skills). The prevalence of Red Flag signs and rates of illnesses, hospitalizations, and chronic conditions were also similar. However, children in the non-AOA group were significantly taller than those in the AOA group (77.1 ± 2.2 cm vs. 74.6 ± 4.0 cm; [ ] = 0.02). Conclusions: Children in the AOA group showed similar psychomotor development at 12 months compared to those in the non-AOA group.

  • Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study

    by Anh M. To, Minh H. N. Nguyen, Tri C. Nguyen, Trung Q. Bui, Yen T. H. Dao, Thanh V. Le, Thao V. Ngo, Toan D. Pham, Tuong M. Ho, Lan N. Vuong

    Objective: To evaluate serum magnesium concentrations in pregnant women with severe pre‐eclampsia being treated with a novel magnesium sulfate regimen for seizure prevention. Methods: This was a prospective, longitudinal study. Pregnant women aged 18 years or older with severe pre‐eclampsia and an indication for treatment with magnesium sulfate were included. Participants received a magnesium sulfate loading dose of 4.5 g over 20 min, then a maintenance dose of 1.5 g/h (the standard regimen at the study center). Serum magnesium concentrations were measured at admission, 30 min, 1, 2, 4, and 6 h, then every 6 h until treatment was stopped. Median (interquartile range [IQR]) serum magnesium concentrations are reported. The primary outcome was serum magnesium concentrations during magnesium sulfate infusion. Results: Serum magnesium concentrations at admission and after 30 min were 0.77 (IQR 0.72–0.82) and 1.81 (IQR 1.63–1.97) mmol/L, respectively. After 4 h, the concentration had decreased slightly to 1.79 (IQR 1.58–2.02) mmol/L. By 12 h, magnesium levels had stabilized at 2 mmol/L. At this time, 50.9% (28/55) had achieved therapeutic magnesium levels (2.0–3.5 mmol/L), and this proportion had increased to 61.7% (29/47) by 24 h. Magnesium toxicity was observed in three patients (4.7%). No cases of eclampsia or maternal mortality were recorded. Conclusions: This magnesium sulfate regimen was generally well tolerated and also prevented seizures even though serum magnesium levels at 24 h were below the currently defined therapeutic range in at least one‐third of participants.

  • Impact of low versus high oxygen tension on human oocyte maturation during biphasic capacitation IVM (CAPA-IVM)

    by Huy H. Pham, Viet Q. Tran, Anh H. Le, Duy L. Nguyen, Toan D. Pham, Anh L. Vu, Tien K. Le, Ho L. Le, Bao G. Huynh, Tuong M. Ho, et al.

    Purpose This study investigated the impact of low versus high oxygen tension on the oocyte maturation rate in biphasic CAPA-IVM. Methods A sibling oocyte pilot study of cumulus-oocyte complexes (COCs) from participants with polycystic ovary syndrome was performed at an academic IVF center in Vietnam from November 2023 to May 2024. At collection, COCs were allocated to undergo CAPA-IVM culture with low oxygen tension (5%) or high oxygen tension (20%). Culture of COCs took place in two benchtop incubators, each equipped with commercial mix-gas bottles to establish the respective oxygen conditions. The primary outcome was the oocyte maturation rate. Secondary outcomes were rates of two-pronuclei fertilization, day-3 embryos, blastocyst formation, and good-quality embryos. Results A total of 554 COCs from 20 participants were assigned to the low oxygen (276 COCs) or high oxygen (278 COCs) tension groups. The oocyte maturation rate was significantly lower in the low oxygen tension versus high oxygen tension group (53.6% vs. 65.8%, risk ratio 0.81, 95% confidence interval 0.71–0.94; p=0.004). The two-pronuclei fertilization rate was significantly lower in the low oxygen tension versus high oxygen tension group (61.5% vs. 72.7%, p=0.03). Numbers of day-3 embryos, blastocysts, and good-quality blastocysts were slightly, but not significantly, lower in the low oxygen tension group compared with the high oxygen tension group. Conclusions Low oxygen tension of 5% during both steps of biphasic CAPA-IVM reduced the number of matured oocytes and 2-pronuclei fertilized oocytes compared with the use of high oxygen tension (20%) during CAPA-IVM.


  • Open Access

    Intracytoplasmic sperm injection versus conventional in vitro fertilization in infertile couples with normal total sperm count and motility: does sperm morphology matter?

    by Toan D Pham, Vinh Q Dang, Vu N A Ho, Cam T Tran, Dung T P Nguyen, Lan N Vuong, Tuong M Ho, Ben W Mol, Rui Wang

    Among couples with infertility and normal total sperm count and motility, can sperm morphology be used as a biomarker to identify couples who benefit more from ICSI over conventional IVF (c-IVF) on fertility outcomes? Based on this secondary analysis of a large randomized clinical trial (RCT), sperm morphology has limited value as a biomarker to identify couples who benefit more from ICSI over c-IVF on live birth, ongoing pregnancy, clinical pregnancy or total fertilization failure. Our recent RCT showed that ICSI did not result in higher live birth rates in couples with normal total sperm count and motility. It is unclear whether sperm morphology can be used as a biomarker to identify couples who benefit more from ICSI over c-IVF in this population. This was a secondary analysis of an open-label, multi-centre, RCT comparing ICSI versus c-IVF in 1064 couples with infertility and normal total sperm count and motility. In this secondary study, we evaluated the effectiveness of ICSI over c-IVF in relation to sperm morphology. Couples were eligible if they had ≤2 previous IVF/ICSI attempts, and the male partner had normal total sperm count and motility according to the fifth edition of the WHO laboratory manual for the examination and processing of human semen. Sperm morphology was measured from samples obtained during the first consultation and data for sperm morphology were available in partners of all participants in this trial. The outcomes of interest were live birth, ongoing pregnancy, clinical pregnancy, and total fertilization failure. We first conducted a logistic regression analysis with an interaction term (sperm morphology as a continuous variable by treatment (ICSI versus c-IVF)) on the four outcomes. We also used restricted cubic spline analysis to evaluate non-linear interaction and plotted the treatment effects of ICSI over c-IVF at different sperm morphology levels and the predicted probability of these outcomes in both ICSI and c-IVF groups. The median proportion of sperm with normal morphology in both groups was 3% (Interquartile range 1–6%). Live birth rates were (184/532) 34.6% for ICSI versus (166/532) 31.2% for c-IVF. No significant interaction was found between sperm morphology and treatment effect of ICSI versus c-IVF on the rates of live birth, ongoing pregnancy, clinical pregnancy, and total fertilization failure (P = 0.181, 0.153, 0.168, and 0.788 respectively). In the analyses using restricted cubic splines, no evidence of interaction between sperm morphology and the treatment effect was found. Interaction figures showed that the treatment effect of ICSI over c-IVF at different sperm morphology levels was fluctuating around no effect line, and the predicted outcomes for the two groups were mostly overlapping at different sperm morphology levels. This secondary analysis may be underpowered to detect a difference in treatment effects at different sperm morphology levels due to relatively small number of events at some sperm morphology levels. Moreover, sperm morphology assessment was performed during the first consultation, rather than on the day of randomization. In couples with infertility and normal total sperm count and motility, sperm morphology has a limited role as a biomarker to identify couples who benefit more from ICSI over c-IVF on fertility outcomes. This study was funded by My Duc Hospital, Ho Chi Minh City, Vietnam. RW was supported by an NHMRC EL Investigator Grant (GNT2009767). LNV has received speaker and conference fees from Merck, grant, speaker, conference fees from Merck Sharpe and Dohme, and speaker, conference, and scientific board fees from Ferring. TMH has received speaker fees from Merck, Merck Sharp Dohme, and Ferring. BWM reports consultancy, travel support and research funding from Merck and consultancy for Organon and Norgine. BWM holds stock from ObsEva. NCT03428919


  • Open Access

    Characteristics of Immunogenicity Against SARS-CoV-2 in a Community-Based Model of Care During the Fourth Wave of COVID-19 Outbreak in Ho Chi Minh City

    by Tu Hoang Kim Trinh, Tuan Diep Tran, Duy Le Pham, Vinh Nhu Nguyen, Quan Tran Thien Vu, Toan Duong Pham, Phong Hoai Nguyen, Minh Kieu Le, Diem Dinh Kieu Truong, Vu Anh Hoang, et al.

    Trinh TH, et al. Yonsei Med J. 2024 Jul;65:e42. https://doi.org/10.3349/ymj.2023.0567